Serum Levels of Anti-Citrullinated Protein Antibody (ACPA) and TWEAK in Patients with Rheumatoid Arthritis: Association with Disease Activity and Treatment Modalities

KARKUCAK, MURAT; ÇAPKIN, ERHAN; Cakirbay, Hasim; Akyuz, Ayse; ALVER, AHMET; CANSU, AYŞEGÜL; Demirok, Duygu; Tosun, Mehmet

doi:10.5606/tjr.2011.032

Serum Levels of Anti-Citrullinated Protein Antibody (ACPA) and TWEAK in Patients with Rheumatoid Arthritis: Association with Disease Activity and Treatment Modalities

Atıf İçin Kopyala

KARKUCAK M. , ÇAPKIN E. , Cakirbay H., Akyuz A., ALVER A. , CANSU A. , ...Daha Fazla

TURKISH JOURNAL OF RHEUMATOLOGY, cilt.26, ss.204-209, 2011 (SCI İndekslerine Giren Dergi)

Cilt numarası: 26 Konu: 3
Basım Tarihi: 2011
Doi Numarası: 10.5606/tjr.2011.032
Dergi Adı: TURKISH JOURNAL OF RHEUMATOLOGY
Sayfa Sayıları: ss.204-209

Özet

Objectives: In this study, we evaluated the serum levels of a serum TNF-related weak inducer of apoptosis (TWEAK) and anti-citrullinated protein antibody (ACPA) and investigated the possible correlation of these parameters with disease activity, cytokine levels and anti-TNF-alpha treatment in patients with rheumatoid arthritis (RA).